866-997-4948(US-Canada Toll Free)

Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Published By :

Transparency Market Research

Published Date : Apr 2017

Category :

Pharmaceutical

No. of Pages : 236 Pages

Global Peptide Therapeutics Market: Overview

This report provides in-depth region wise and country wise analysis of the peptide therapeutics market. Stakeholders of this report include manufacturers of peptide products, raw material suppliers, nutraceutical and cosmeceutical companies, food processing industries and new players planning to enter the market. It further provides qualitative and quantitative analysis of the global peptide therapeutics market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes major players with their reported revenue, market size, and forecast for the global peptide therapeutics market in major countries globally such as the U.S., Canada, Germany, France, United Kingdom, Switzerland, Spain, Japan, China, Brazil, Mexico, South Africa and Saudi Arabia

 Market revenue is provided in terms of US$ Mn from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 for all the segments, considering 2015 as the base year. The executive summary of the report provides a snapshot of the peptide therapeutics with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors. Moreover, the report also includes pricing analysis for the major peptide drugs worldwide. 

The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global peptide therapeutics market. These factors would aid the stakeholders in establishing a strong foothold in the global peptide therapeutics market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the peptide therapeutics market. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.

Global Peptide Therapeutics Market: Segmentation

The peptide therapeutics market has been segmented as by application, by route of administration, by type, by technology, by type of molecule, by API peptide type and by geography. Based on application, the market has been segmented into cancer, metabolic, CVD, respiratory, GIT, anti-infective, dermatology, CNS, renal and others. Based on route of administration, the market has been segmented into parenteral, oral and others.

Based on type, the market has been segmented into innovative and generic. Based on technology, the market has been segmented into liquid phase, solid phase and hybrid phase. Based on type of molecules, the market has been segmented into vasopressin, somatostatin, calcitonin, immunopeptide, natriuretic and others. Based on API peptide type, the market has been segmented into in-house and CMO.

Geographically, the peptide therapeutics market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Brazil, Mexico, Rest of LATAM, South Africa, Saudi Arabia, Rest of MEA have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the peptide therapeutics market in various regions has been provided in this section. It also includes various ups and downs about particular country or geography that has impacted the overall market globally.

Global Peptide Therapeutics Market: Competitive Analysis

The report provides a detailed outline/blueprint of the peptide therapeutics market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. It concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Sanofi, Teva Pharmaceutical Industries Ltd., Novo Nordisk, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Pfizer, Inc. and others.

The global peptide therapeutics market has been segmented into:

By Application

  • Cancer
  • Metabolic
  • CVD
  • Respiratory
  • GIT
  • Anti-infective
  • Dermatology
  • CNS
  • Renal
  • Others

By Route of Administration

  • Parenteral
  • Oral
  • Others

By Type

  • Innovative
  • Generic

By Technology

  • Liquid Phase
  • Solid Phase
  • Hybrid Phase

By Type of Molecule

  • Vasopressin
  • Somatostatin
  • Calcitonin
  • Immunopeptide
  • Natriuretic
  • Others

By API Peptide Type

  • In-house
  • CMO

By Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific (APAC)
  • Japan
  • China
  • India
  • Rest of APAC
  • Latin America (LATAM)
  • Brazil
  • Mexico
  • Rest of LATAM
  • Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Rest of MEA

Table of Content

1. Preface
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Objectives
1.4. Key Questions Answered

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Acronyms Used
2.3. Research Methodology

3. Executive Summary
3.1. Global Peptide Therapeutics Market Snapshot
3.2. Market Opportunity Map

4. Market Overview
4.1. Product Overview
4.2. Death Rate of Leukemia, by Country
4.3. Death Rate of Cancer, by Country

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Opportunity Analysis
5.6. White Space Analysis
5.7. Porter’s Analysis
5.8. Pipeline Analysis (Phase III)
5.9. Peptide Drug Chemical Structure Trend Analysis
5.10. Separation Media for Peptide Drug Manufacturing

6. Global Peptide Therapeutics Market Analysis, by Application
6.1. Key Findings
6.2. Introduction
6.3. Cancer
6.4. Metabolic
6.5. CVD
6.6. Respiratory
6.7. GIT
6.8. Anti-infective
6.9. Dermatology
6.10. CNS
6.11. Renal
6.12. Others
6.13. Key Trends
6.14. Market Attractiveness Analysis

7. Global Peptide Therapeutics Market Analysis, by Route of Administration
7.1. Key Findings
7.2. Introduction
7.3. Parenteral
7.4. Oral
7.5. Others
7.6. Key Trends
7.7. Market Attractiveness Analysis

8. Global Peptide Therapeutics Market Analysis, by Type
8.1. Key Findings
8.2. Introduction
8.3. Innovative
8.4. Generic
8.5. Key Trends
8.6. Market Attractiveness Analysis

9. Global Peptide Therapeutics Market Analysis, by Technology
9.1. Key Findings
9.2. Introduction
9.3. Liquid Phase
9.4. Solid Phase
9.5. Hybrid Phase
9.6. Market Attractiveness Analysis

10. Global Peptide Therapeutics Market Analysis, by Type of Molecule
10.1. Key Findings
10.2. Introduction
10.3. Vasopressin
10.4. Somatostatin
10.5. Calcitonin
10.6. Immunopeptide
10.7. Natriuretic
10.8. Others
10.9. Market Attractiveness Analysis

11. Global API Peptide Therapeutics Market Analysis, by Type
11.1. Key Findings
11.2. Introduction
11.3. In-house
11.4. CMO
11.5. Market Attractiveness Analysis

12. Global Peptide Therapeutics Market Analysis, by Region
12.1. Regulatory Framework
12.2. North America
12.3. Europe
12.4. Asia Pacific
12.5. Latin America
12.6. Middle East & Africa
12.7. Market Attractiveness Analysis

13. North America Peptide Therapeutics Market Analysis
13.1. North America Peptide Therapeutics Market Size Forecast, By Country, 2016-2024
13.2. North America Peptide Therapeutics Therapy Market Size Forecast, By Application, 2016-2024
13.3. North America Peptide Therapeutics Market Size Forecast, By Route of Administration, 2016-2024
13.4. North America Peptide Therapeutics Market Size Forecast, By Type, 2016-2024
13.5. North America Peptide Therapeutics Market Size Forecast, By Technology, 2016-2024
13.6. North America Peptide Therapeutics Market Attractiveness Analysis, 2016-2024

14. Europe Peptide Therapeutics Market Analysis
14.1. Europe Peptide Therapeutics Market Size Forecast, By Country, 2016-2024
14.2. Europe Peptide Therapeutics Therapy Market Size Forecast, By Application, 2016-2024
14.3. Europe Peptide Therapeutics Market Size Forecast, By Route of Administration, 2016-2024
14.4. Europe Peptide Therapeutics Market Size Forecast, By Type, 2016-2024
14.5. Europe Peptide Therapeutics Market Size Forecast, By Technology, 2016-2024
14.6. Europe Peptide Therapeutics Market Attractiveness Analysis, 2016-2024

15. Asia Pacific Peptide Therapeutics Market Analysis
15.1. Asia Pacific Peptide Therapeutics Market Size Forecast, By Country, 2016-2024
15.2. Asia Pacific Peptide Therapeutics Therapy Market Size Forecast, By Application, 2016-2024
15.3. Asia Pacific Peptide Therapeutics Market Size Forecast, By Route of Administration, 2016-2024
15.4. Asia Pacific Peptide Therapeutics Market Size Forecast, By Type, 2016-2024
15.5. Asia Pacific Peptide Therapeutics Market Size Forecast, By Technology, 2016-2024
15.6. Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, 2016-2024

16. Latin America Peptide Therapeutics Market Analysis
16.1. Latin America Peptide Therapeutics Market Size Forecast, By Country, 2016-2024
16.2. Latin America Peptide Therapeutics Therapy Market Size Forecast, By Application, 2016-2024
16.3. Latin America Peptide Therapeutics Market Size Forecast, By Route of Administration, 2016-2024
16.4. Latin America Peptide Therapeutics Market Size Forecast, By Type, 2016-2024
16.5. Latin America Peptide Therapeutics Market Size Forecast, By Technology, 2016-2024
16.6. Latin America Peptide Therapeutics Market Attractiveness Analysis, 2016-2024
16.7. Latin America Peptide Therapeutics Market Attractiveness Analysis

17. Middle East & Africa Peptide Therapeutics Market Analysis
17.1. Middle East & Africa Peptide Therapeutics Market Size Forecast, By Country, 2016-2024
17.2. Middle East & Africa Peptide Therapeutics Therapy Market Size Forecast, By Application, 2016-2024
17.3. Middle East & Africa Peptide Therapeutics Market Size Forecast, By Route of Administration, 2016-2024
17.4. Middle East & Africa Peptide Therapeutics Market Size Forecast, By Type, 2016-2024
17.5. Middle East & Africa Peptide Therapeutics Market Size Forecast, By Technology, 2016-2024
17.6. Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, 2016-2024

18. Competitive Landscape
18.1. Market Share Analysis by Company (2015)
18.2. Competition Matrix
18.2.1. Teva Pharmaceutical Industries Ltd.
18.2.2. GlaxoSmithKline
18.2.3. Novartis AG
18.2.4. Pfizer, Inc.
18.2.5. F. Hoffmann-La Roche Ltd.
18.2.6. Bachem Holding AG
18.2.7. Sanofi

19. Company Profiles
19.1. Amgen, Inc.
19.1.1. Company Details
19.1.2. Company Description
19.1.3. Business Overview
19.1.4. SWOT Analysis
19.1.5. Financial Analysis
19.1.6. Strategic Overview
19.2. Bachem Holding AG
19.2.1. Company Details
19.2.2. Company Description
19.2.3. Business Overview
19.2.4. SWOT Analysis
19.2.5. Financial Analysis
19.2.6. Strategic Overview
19.3. Eli Lilly and Company
19.3.1. Company Details
19.3.2. Company Description
19.3.3. Business Overview
19.3.4. SWOT Analysis
19.3.5. Financial Analysis
19.3.6. Strategic Overview
19.4. F. Hoffmann-La Roche Ltd.
19.4.1. Company Details
19.4.2. Company Description
19.4.3. Business Overview
19.4.4. SWOT Analysis
19.4.5. Financial Analysis
19.4.6. Strategic Overview
19.5. GlaxoSmithKline Plc
19.5.1. Company Details
19.5.2. Company Description
19.5.3. Business Overview
19.5.4. SWOT Analysis
19.5.5. Financial Analysis
19.5.6. Strategic Overview
19.6. Novartis AG
19.6.1. Company Details
19.6.2. Company Description
19.6.3. Business Overview
19.6.4. SWOT Analysis
19.6.5. Financial Analysis
19.6.6. Strategic Overview
19.7. Pfizer, Inc.
19.7.1. Company Details
19.7.2. Company Description
19.7.3. Business Overview
19.7.4. SWOT Analysis
19.7.5. Financial Analysis
19.7.6. Strategic Overview
19.8. Sanofi
19.8.1. Company Details
19.8.2. Company Description
19.8.3. Business Overview
19.8.4. SWOT Analysis
19.8.5. Financial Analysis
19.8.6. Strategic Overview
19.9. Takeda Pharmaceutical Company Limited
19.9.1. Company Details
19.9.2. Company Description
19.9.3. Business Overview
19.9.4. SWOT Analysis
19.9.5. Financial Analysis
19.9.6. Strategic Overview
19.10. Teva Pharmaceutical Industries Ltd.
19.10.1. Company Details
19.10.2. Company Description
19.10.3. Business Overview
19.10.4. SWOT Analysis
19.10.5. Financial Analysis
19.10.6. Strategic Overview

List of Table

TABLE 1 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 2 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2024
TABLE 3 Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 4 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2016–2024
TABLE 5 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2016–2024
TABLE 6 API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 7 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Region, 2016–2024
TABLE 8 North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 9 North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 10 North America Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2016–2024
TABLE 11 North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 12 North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2016–2024
TABLE 13 North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2016–2024
TABLE 14 North America API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 15 Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 16 Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 17 Europe Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2016–2024
TABLE 18 Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 19 Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2016–2024
TABLE 20 Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2016–2024
TABLE 21 Europe API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 22 Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 23 Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 24 Asia Pacific Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2016–2024
TABLE 25 Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 26 Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2016–2024
TABLE 27 Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2016–2024
TABLE 28 Asia Pacific API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 29 Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 30 Latin America  Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 31 Latin America Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2016–2024
TABLE 32 Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 33 Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2016–2024
TABLE 34 Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2016–2024
TABLE 35 Latin America API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 36 Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 37 Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 38 Middle East & Africa Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2016–2024
TABLE 39 Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 40 Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2016–2024
TABLE 41 Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2016–2024
TABLE 42 Middle East & Africa API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024

List of Chart

FIG. 1 Global Peptide Therapeutics Market Value Share Analysis, by Application, 2015 and 2024
FIG. 2 Global Cancer Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 3 Global Metabolic Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 4 Global CVD Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 5 Global Respiratory Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 6 Global GIT Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 7 Global Anti-infective Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 8 Global Dermatology Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 9 Global CNS Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 10 Global Renal Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 11 Global Others Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 12 Peptide Therapeutics Market Attractiveness Analysis, by Application
FIG. 13 Global Peptide Therapeutics Market Value Share Analysis, by Route of Administration, 2015 and  2024
FIG. 14 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Parenteral, 2016–2024
FIG. 15 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Oral, 2016–2024
FIG. 16 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Others, 2016–2024
FIG. 17 Global Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration
FIG. 18 Peptide Therapeutics Market Value Share Analysis, by Type, 2015 and 2024
FIG. 19 Innovative Peptide Therapeutics Market Size (US$ Mn), 2016–2024
FIG. 20 Generic Peptide Therapeutics Market Size (US$ Mn), 2016–2024
FIG. 21 Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 22 Global Peptide Therapeutics Market Value Share Analysis, by Technology, 2015 and 2024
FIG. 23 Global Liquid Phase Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 24 Global Solid Phase Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 25 Global Hybrid Phase Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 26 Global Peptide Therapeutics Market Attractiveness Analysis, by Technology
FIG. 27 Global Peptide Therapeutics Market Value Share Analysis, by Type of Molecules, 2015 and 2024
FIG. 28 Global Vasopressin Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 29 Global Somatostatins Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 30 Global Calcitonin Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 31 Global Immunopeptides Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 32 Global Natriuretic Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 33 Global Other Peptides Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 34 Peptide Therapeutics Market Attractiveness Analysis, by Type of Molecule
FIG. 35 API Peptide Therapeutics Market Value Share Analysis, by Type, 2015 and 2024
FIG. 36 In-house Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 37 CMO Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 38 API Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 39 North America Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 40 Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 41 Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 42 Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 43 MEA Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 44 Global Peptide Therapeutics Market Attractiveness Analysis, by Region
FIG. 45 U.S. Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 46 Canada Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 47 North America Peptide Therapeutics Market Attractiveness Analysis, by Country
FIG. 48 North America Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration
FIG. 49 North America Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 50 North America Peptide Therapeutics Market Attractiveness Analysis, by Technology
FIG. 51 Germany Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 52 U.K. Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 53 France Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 54 Italy Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 55 Spain Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 56 Rest of Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 57 Europe Peptide Therapeutics Market Attractiveness Analysis, by Country
FIG. 58 Europe Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration
FIG. 59 Europe Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 60 Europe Peptide Therapeutics Market Attractiveness Analysis, by Technology
FIG. 61 Japan Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 62 China Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 63 India Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 64 Rest of APAC Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 65 Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, by Country
FIG. 66 Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration
FIG. 67 Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 68 Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, by Technology
FIG. 69 Brazil Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 70 Mexico Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 71 Rest of LATAM Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 72 Latin America Peptide Therapeutics Market Attractiveness Analysis, by Country
FIG. 73 Latin America Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration
FIG. 74 Latin America Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 75 Latin America Peptide Therapeutics Market Attractiveness Analysis, by Technology
FIG. 76 South Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 77 Saudi Arabia Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 78 Rest of MEA Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 79 Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, by Country
FIG. 80 Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration
FIG. 81 Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 82 Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, by Technology
FIG. 83 Peptide Therapeutics Market Share Analysis By Company (2015)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *